Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
5
Bullish
6
Bearish
30
Neutral
5
Bullish
11
Bearish
27
Neutral
0
Bullish
5
Bearish
3
Neutral
5
Bullish
6
Bearish
3
Neutral
5
Bullish
6
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Vasundhara Rasayans Limited is an Indian manufacturer and exporter of antacid active pharmaceutical ingredients (APIs), operating since 1990 with an annual installed capacity of about 1,500 metric tonnes and manufacturing facilities in Mahad (Maharashtra) and an intermediate organics/Friedel–Crafts reaction facility, maintained to GMP standards and focused on powder, paste and micronised product forms.
The company reported unaudited Q1 FY2026–27 results showing total income of INR 730.10 lakhs and a net profit after tax of INR 64.80 lakhs; the results were reviewed by the audit committee and carry an unmodified limited review report from the statutory auditor, signalling no qualification on interim financial reporting for the quarter ended 30 June 2026.
Operationally the company highlights a closed-system spray drier and a specialised intermediate plant enabling high-temperature, low-contamination drying and complex organic syntheses; these process capabilities are core differentiators for antacid API quality and export compliance, and the plant’s location provides logistical proximity to Mumbai ports for export-focused sales.
An unusual disclosure appears in the financial notes where the company states it has only one reportable segment, 'viz agri products', which contrasts with the corporate description as an antacid API manufacturer and exporter; this discrepancy merits clarification from management as it could affect investor understanding of revenue classification and reporting comparability.
Pharmaceuticals & Biotechnology
Pharmaceuticals
43 Cr
Moderate Risk
7.3
34.8
6.2
1.1
220.00
100.10
Sales CAGR
Profit CAGR
ROE
ROCE
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Vasundhara Rasayans Ltd (VRL) is currently trading at 134.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Vasundhara Rasayans Limited is an Indian manufacturer and exporter of antacid active pharmaceutical ingredients (APIs), operating since 1990 with an annual installed capacity of about 1,500 metric tonnes and manufacturing facilities in Mahad (Maharashtra) and an intermediate organics/Friedel–Crafts reaction facility, maintained to GMP standards and focused on powder, paste and micronised product forms. The company reported unaudited Q1 FY2026–27 results showing total income of INR 730.10 lakhs and a net profit after tax of INR 64.80 lakhs; the results were reviewed by the audit committee and carry an unmodified limited review report from the statutory auditor, signalling no qualification on interim financial reporting for the quarter ended 30 June 2026. Operationally the company highlights a closed-system spray drier and a specialised intermediate plant enabling high-temperature, low-contamination drying and complex organic syntheses; these process capabilities are core differentiators for antacid API quality and export compliance, and the plant’s location provides logistical proximity to Mumbai ports for export-focused sales. An unusual disclosure appears in the financial notes where the company states it has only one reportable segment, 'viz agri products', which contrasts with the corporate description as an antacid API manufacturer and exporter; this discrepancy merits clarification from management as it could affect investor understanding of revenue classification and reporting comparability.
Over the past 52 weeks, Vasundhara Rasayans Ltd has traded between a low of ₹100.10 and a high of ₹220.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Vasundhara Rasayans Ltd has a market capitalization of approximately 42.86. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Vasundhara Rasayans Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 7.25 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 42.86 Cr, Vasundhara Rasayans Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Vasundhara Rasayans Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Vasundhara Rasayans Ltd is 7.25. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
28.17 | 46 Cr | 95.48 | 2.13 | 0.00 | 12.92 | 14.07 | 1.12 | ||
28.00 | 44 Cr | -1.16 | 0.46 | 0.00 | -43.08 | -15.40 | -12.14 | ||
33.00 | 43 Cr | -3.23 | 0.89 | 0.00 | -20.96 | -3.83 | -6.37 | ||
134.85 | 43 Cr | 7.25 | 1.05 | 1.48 | 14.16 | 19.37 | 12.34 | ||
9.27 | 40 Cr | -2.22 | 0.00 | 0.00 | -22.95 | -11.16 | -9.61 | ||
16.15 | 38 Cr | 5.04 | 1.29 | 0.00 | 16.75 | 19.05 | 8.80 | ||
24.55 | 37 Cr | -9.09 | 0.96 | 0.00 | -13.99 | -10.62 | -7.79 | ||
| Median: 7 Co. | — | 28.00 | 43 Cr | -1.16 | 0.96 | 0.00 | -13.99 | -3.83 | -6.37 |
